Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 63 citing Desai: Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression. (0.08 sec) 

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

- itmhrt.ca [PDF] 
C Esau, S Davis, SF Murray, XX Yu, SK … - Cell metabolism, 2006 - Elsevier
Current understanding of microRNA (miRNA) biology is limited, and antisense
oligonucleotide (ASO) inhibition of miRNAs is a powerful technique for their
functionalization. To uncover the role of the liver-specific miR-122 in the ...
Cited by 237 - Related articles - All 14 versions

Allosteric activators of glucokinase: potential role in diabetes therapy

- sciencesignaling.org [PDF] 
J Grimsby, R Sarabu, WL Corbett, NE Haynes, … - Science, 2003 - sciencemag.org
Page 1. DOI: 10.1126/science.1084073 , 370 (2003); 301 Science et al. Joseph Grimsby,
in Diabetes Therapy Allosteric Activators of Glucokinase: Potential Role ...
Cited by 187 - Related articles - All 12 versions

Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian …

- jbc.org
K Oishi, K Miyazaki, K Kadota, R Kikuno, T … - Journal of Biological Chemistry, 2003 - ASBMB
CLOCK is a positive component of a transcription/translation-based negative
feedback loop of the central circadian oscillator in the suprachiasmatic nucleus
in mammals. To examine CLOCK-regulated circadian transcription in ...
Cited by 135 - Related articles - BL Direct - All 5 versions

Glucokinase (GCK) mutations in hyper-and hypoglycemia: maturity-onset diabetes of the …


AL Gloyn - Human mutation, 2003 - interscience.wiley.com
Glucokinase is a key regulatory enzyme in the pancreatic beta-cell. It plays a
crucial role in the regulation of insulin secretion and has been termed the
pancreatic beta-cell sensor. Given its central role in the regulation of ...
Cited by 121 - Related articles - BL Direct - All 6 versions

Insights into the biochemical and genetic basis of glucokinase activation from naturally …

- diabetesjournals.org
AL Gloyn, K Noordam, MAAP Willemsen, S … - Diabetes, 2003 - Am Diabetes Assoc
Glucokinase (GCK) is a key regulatory enzyme in the pancreatic β-cell and
catalyzes the rate-limiting step for β-cell glucose metabolism. We report two
novel GCK mutations (T65I and W99R) that have arisen de novo in two ...
Cited by 78 - Related articles - BL Direct - All 5 versions

Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase …

- ox.ac.uk [PDF] 
KJ Brocklehurst, VA Payne, RA Davies, D … - Diabetes, 2004 - Am Diabetes Assoc
Glucokinase (GK) has a major role in the control of blood glucose homeostasis
and is a strong potential target for the pharmacological treatment of type 2
diabetes. We report here the mechanism of action of two novel and potent ...
Cited by 75 - Related articles - BL Direct - All 6 versions

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and …


XX Yu, SF Murray, SK Pandey, SL Booten, D … - Hepatology, 2005 - interscience.wiley.com
In this study, we investigated the role of acyl-coenzyme A:diacylglycerol
acyltransferase 2 (DGAT2) in glucose and lipid metabolism in obese mice by
reducing its expression in liver and fat with an optimized antisense ...
Cited by 73 - Related articles - BL Direct - All 3 versions

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice …


RM Crooke, MJ Graham, KM Lemonidis, CP … - The Journal of Lipid Research, 2005 - ASBMB
High levels of plasma apolipoprotein B-100 (apoB-100), the principal
apolipoprotein of LDL, are associated with cardiovascular disease. We
hypothesized that suppression of apoB-100 mRNA by an antisense ...
Cited by 72 - Related articles - All 4 versions

Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in …

- jlr.org
MJ Graham, KM Lemonidis, CP Whipple, A … - The Journal of Lipid Research, 2007 - ASBMB
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a member of a family of
proteases that is thought to promote the degradation of the low density
lipoprotein receptor (LDLR) through an as yet undefined mechanism. We ...
Cited by 45 - Related articles - All 4 versions

Gene therapy vector-mediated expression of insulin-like growth factors protects …

- physiology.org
EJ Su, CL Cioffi, S Stefansson, N Mittereder, … - American Journal of Physiology- Heart and Circulatory …, 2003 - Am Physiological Soc
IGF-I and IGF-II are single-chain polypeptide growth factors that regulate
pleiotropic cellular responses. We have characterized the effect of recombinant
IGF proteins, as well as third-generation adenoviral vectors encoding ...
Cited by 29 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google